|
C1ORF25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.37559999963722E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.477100E-03 |
| Normal-vs-Stage2 |
1.651590E-01 |
| Normal-vs-Stage3 |
5.49109999692377E-08 |
| Normal-vs-Stage4 |
4.23109991487536E-10 |
| Stage1-vs-Stage2 |
8.808000E-01 |
| Stage1-vs-Stage3 |
2.704300E-03 |
| Stage1-vs-Stage4 |
4.22700000000109E-05 |
| Stage2-vs-Stage3 |
1.011570E-01 |
| Stage2-vs-Stage4 |
3.606300E-02 |
| Stage3-vs-Stage4 |
4.096400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79559999996726E-06 |
| Normal-vs-AfricanAmerican |
7.88559999520544E-08 |
| Normal-vs-Asian |
2.906400E-02 |
| Caucasian-vs-AfricanAmerican |
2.106300E-02 |
| Caucasian-vs-Asian |
7.219000E-01 |
| AfricanAmerican-vs-Asian |
6.616600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99789999678313E-08 |
| Normal-vs-Female |
1.960130E-03 |
| Male-vs-Female |
5.564300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.191930E-04 |
| Normal-vs-Age(41-60Yrs) |
1.999520E-04 |
| Normal-vs-Age(61-80Yrs) |
7.66780000049927E-07 |
| Normal-vs-Age(81-100Yrs) |
4.960200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.837640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.100400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.646200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.255400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.737600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.571600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.703400E-01 |
| Normal-vs-Grade 2 |
1.679750E-02 |
| Normal-vs-Grade 3 |
1.83629999983559E-07 |
| Normal-vs-Grade 4 |
1.74715797385261E-12 |
| Grade 1-vs-Grade 2 |
4.626400E-01 |
| Grade 1-vs-Grade 3 |
3.280300E-02 |
| Grade 1-vs-Grade 4 |
5.60609999999961E-05 |
| Grade 2-vs-Grade 3 |
9.216100E-03 |
| Grade 2-vs-Grade 4 |
1.45820000518881E-08 |
| Grade 3-vs-Grade 4 |
3.002900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.521400E-01 |
| Normal-vs-ccB subtype |
2.7237101463129E-12 |
| ccA subtype-vs-ccB subtype |
1.69964042839865E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.35340000000517E-05 |
| Normal-vs-N1 |
2.804200E-04 |
| N0-vs-N1 |
2.911800E-01 |
|
|
